Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Gene therapy: where do we stand?].
Cavazzana-Calvo M. Cavazzana-Calvo M. Rev Prat. 2013 Apr;63(4):457-61. Rev Prat. 2013. PMID: 23682464 French.
Gene therapy for primary immunodeficiencies: Part 1.
Cavazzana-Calvo M, Fischer A, Hacein-Bey-Abina S, Aiuti A. Cavazzana-Calvo M, et al. Curr Opin Immunol. 2012 Oct;24(5):580-4. doi: 10.1016/j.coi.2012.08.008. Epub 2012 Sep 12. Curr Opin Immunol. 2012. PMID: 22981681 Review.
Gene therapy for immunodeficiency diseases.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. Semin Hematol. 2004 Oct;41(4):272-8. doi: 10.1053/j.seminhematol.2004.07.003. Semin Hematol. 2004. PMID: 15508112 Review.
Gene therapy of metabolic diseases.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):409-12. doi: 10.1007/s10545-006-0270-7. J Inherit Metab Dis. 2006. PMID: 16763910 Review.
Gene therapy for primary adaptive immune deficiencies.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. J Allergy Clin Immunol. 2011 Jun;127(6):1356-9. doi: 10.1016/j.jaci.2011.04.030. J Allergy Clin Immunol. 2011. PMID: 21624615 Review.
Gene therapy of primary T cell immunodeficiencies.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. Among authors: cavazzana calvo m. Gene. 2013 Aug 10;525(2):170-3. doi: 10.1016/j.gene.2013.03.092. Epub 2013 Apr 10. Gene. 2013. PMID: 23583799 Free article. Review.
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrère F, Blanche S, Audit M, Payen E, Leboulch P, l'Homme B, Bougnères P, Von Kalle C, Fischer A, Cavazzana-Calvo M, Aubourg P. Cartier N, et al. Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242. Science. 2009. PMID: 19892975
Gene therapy for primary immunodeficiencies.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. Immunol Allergy Clin North Am. 2010 May;30(2):237-48. doi: 10.1016/j.iac.2010.02.002. Immunol Allergy Clin North Am. 2010. PMID: 20493399 Review.
[Curing a congenital immunologic deficiency].
Mahlaoui N, Cavazzana-Calvo M. Mahlaoui N, et al. Rev Prat. 2007 Oct 15;57(15):1699-700. Rev Prat. 2007. PMID: 18080429 French. No abstract available.
199 results